SouthState Corp Acquires 218 Shares of Colgate-Palmolive (NYSE:CL)

SouthState Corp lifted its holdings in Colgate-Palmolive (NYSE:CL) by 3.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,257 shares of the company’s stock after purchasing an additional 218 shares during the quarter. SouthState Corp’s holdings in Colgate-Palmolive were worth $499,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in CL. &PARTNERS raised its stake in Colgate-Palmolive by 0.7% during the 4th quarter. &PARTNERS now owns 17,643 shares of the company’s stock worth $1,406,000 after buying an additional 129 shares during the period. West Branch Capital LLC lifted its holdings in shares of Colgate-Palmolive by 24.0% in the 4th quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after purchasing an additional 132 shares in the last quarter. First Foundation Advisors grew its position in Colgate-Palmolive by 2.7% in the 3rd quarter. First Foundation Advisors now owns 5,226 shares of the company’s stock valued at $372,000 after purchasing an additional 136 shares during the period. Waldron Private Wealth LLC increased its stake in Colgate-Palmolive by 2.7% during the 3rd quarter. Waldron Private Wealth LLC now owns 5,361 shares of the company’s stock valued at $381,000 after purchasing an additional 140 shares in the last quarter. Finally, Autumn Glory Partners LLC raised its holdings in Colgate-Palmolive by 2.7% during the fourth quarter. Autumn Glory Partners LLC now owns 5,319 shares of the company’s stock worth $424,000 after buying an additional 140 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insiders Place Their Bets

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the transaction, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at approximately $22,797,983.85. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Noel R. Wallace sold 69,948 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total value of $5,891,020.56. Following the transaction, the chief executive officer now owns 286,881 shares in the company, valued at approximately $24,161,117.82. The disclosure for this sale can be found here. Insiders sold 159,048 shares of company stock valued at $13,336,846 over the last three months. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock traded down $0.03 during trading on Friday, hitting $92.88. The stock had a trading volume of 5,432,692 shares, compared to its average volume of 4,690,854. The firm has a market cap of $76.20 billion, a price-to-earnings ratio of 29.39, a P/E/G ratio of 3.39 and a beta of 0.40. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $93.25. The business’s 50-day moving average is $88.22 and its 200 day moving average is $82.07. The company has a current ratio of 1.06, a quick ratio of 0.28 and a debt-to-equity ratio of 13.21.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, beating analysts’ consensus estimates of $0.82 by $0.04. The business had revenue of $5.07 billion for the quarter, compared to the consensus estimate of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. Colgate-Palmolive’s quarterly revenue was up 6.2% on a year-over-year basis. During the same period last year, the firm posted $0.73 earnings per share. As a group, sell-side analysts anticipate that Colgate-Palmolive will post 3.52 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 2.15%. The ex-dividend date of this dividend is Friday, April 19th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 63.29%.

Wall Street Analyst Weigh In

Several analysts have recently commented on the company. Citigroup increased their price objective on Colgate-Palmolive from $95.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, April 16th. Bank of America upped their target price on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday. StockNews.com lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 20th. UBS Group upped their price objective on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, January 29th. Finally, Evercore ISI lifted their target price on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the stock an “outperform” rating in a research report on Monday, April 8th. Three research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $91.44.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.